EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ETS Variant Transcription Factor 6 Promotes Glucose Metabolism Reprogramming in HCC

Chunmei Guo iD, Lingqian Xie, Huiqing Yin, Lina Yi, Lin Jin, Xiangwei Liu, Qingqing Zhang, Zijian Li, Shuqing Liu, Ming-Zhong Sun iD

Journal of Cellular and Molecular Medicine · 2026-02 · 30 (3)

DOI: 10.1111/jcmm.71029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 03.02.2026. Verfasst von Chunmei Guo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning, China. Hauptthemen laut MEDLINE: Glucose, Liver Neoplasms, Proto-Oncogene Proteins c-ets, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Department of Education of Liaoning Province, Natural Science Foundation of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucose metabolic reprogramming is a key hallmark of tumour cells, and the designed inhibitors targeting tumour glucose metabolism reprogramming may serve as an effective therapeutic strategy. The ETS Variant Transcription Factor 6 (ETV6) is a potent transcriptional repressor strongly associated with tumorgenesis. However, the precise role and underlying action mechanism of ETV6 in tumour glucose metabolism reprogramming remain unreported. In this study, we demonstrate that the ETV6‐miR‐429‐CRKL regulatory axis contributes to metabolism reprogramming in HCC. Overexpression or knockdown of ETV6 and CRKL enhances or inhibits the Warburg effect and glycogen synthesis in HCC cells both in vitro and in vivo. In contrast, miR‐429 overexpression and knockdown exert opposing effects on the Warburg effect compared to the overexpression and knockdown of ETV6 and CRKL. Moreover, miR‐429 regulates the rate of glycogen production and degradation by enhancing the activities of GCS and GPa to promote glycogen synthesis, subsequently coupling with the aerobic glycolytic pathway by mediating glycogen shunting. Mechanistically, ETV6 binds to the miR‐429 promoter, mediating glucose metabolic reprogramming in HCC cells by targeting CRKL via the PI3K/AKT pathway. Taken together, these findings reveal that the ETV6‐miR‐429‐CRKL regulatory circuitry plays a crucial role in glucose metabolic reprogramming in HCC, offering novel insight and a potential target for cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucoseLiver NeoplasmsProto-Oncogene Proteins c-etsCarcinoma, HepatocellularRepressor ProteinsHumansMetabolic ReprogrammingMicroRNAsAnimalsGene Expression Regulation, NeoplasticGlycogenETS Translocation Variant 6 ProteinCell Line, TumorPhosphatidylinositol 3-KinasesSignal TransductionProto-Oncogene Proteins c-akt

Stichwörter der Autor:innen

CRKLETV6PI3K/AKT pathwayglucose metabolism reprogrammingglycogen shuntmiR‐429

Substanzen

GlucoseProto-Oncogene Proteins c-etsMicroRNAsRepressor ProteinsGlycogenETS Translocation Variant 6 ProteinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Biotechnology, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning, China.
  • Department of Biochemistry, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning, China.
  • Department of Pathology and Forensic Medicine, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning, China.
  • Liaoning Key Laboratory of Cancer Stem Cell Research, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning, China.

ORCID-Profile: Chunmei Guo, Ming-Zhong Sun

Förderung

  • National Natural Science Foundation of China
  • Department of Education of Liaoning Province
  • Natural Science Foundation of Liaoning Province

Zitieren

APA

Guo, C., Xie, L., Yin, H., Yi, L., Jin, L., Liu, X., Zhang, Q., Li, Z., Liu, S., & Sun, M. Z. (2026). ETS Variant Transcription Factor 6 Promotes Glucose Metabolism Reprogramming in HCC. Journal of Cellular and Molecular Medicine, 30(3). https://doi.org/10.1111/jcmm.71029

Vancouver

Guo C, Xie L, Yin H, Yi L, Jin L, Liu X, et al. ETS Variant Transcription Factor 6 Promotes Glucose Metabolism Reprogramming in HCC. Journal of Cellular and Molecular Medicine. 2026;30(3). doi:10.1111/jcmm.71029

BibTeX
@article{Guo2026,
  author = {Guo, Chunmei and Xie, Lingqian and Yin, Huiqing and Yi, Lina and Jin, Lin and Liu, Xiangwei and Zhang, Qingqing and Li, Zijian and Liu, Shuqing and Sun, Ming-Zhong},
  title = {ETS Variant Transcription Factor 6 Promotes Glucose Metabolism Reprogramming in HCC},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {3},
  doi = {10.1111/jcmm.71029}
}
Kostenlos starten →